Recent Posts – Emmanuel Thomas M.D. Ph.D. FAASLD

07May 2020 by admin

Dr. Thomas is helping lead the HCV Elimination Program in Florida.

The FL HCV elimination group convened national and local experts in August 2019 in Orlando, FL for its inaugural meeting to address screening, treatment-level barriers and liver cancer prevention. The meeting goal was to support a statewide HCV elimination program and it was attended by stakeholders including representatives from the FL DOH, patients, medical and social service providers, researchers, policymakers and others from private organizations. This followed an earlier HCV elimination meeting in February 2019, held in Miami, FL by the major liver disease societies (AASLD/EASL). Planned activities will strengthen and be synergistic with the current efforts from the FL DOH viral hepatitis program and include involvement of four major academic centers in FL. Stakeholders will continue to meet in 2020 with the goal of producing a guidance document with…

07May 2020 by admin

Dr. Thomas presented in the Antibody Testing and Treatment Recommendations webinar as part of the AASLD’s ongoing series.

Dr. Thomas presented in the Antibody Testing and Treatment Recommendations webinar hosted by the American Association for the Study of Liver Diseases. The webinar took place on April 30th, 2020 as part of the COVID-19 and the Liver series by the AASLD COVID-19 Working Group. The COVID-19 and the Liver series is dedicated to presenting discoveries and discussions about COVID-19 and how it impacts the care of liver patients. The Antibody Testing and Treatment Recommendations webinar is the fourth in the series. This session was designed to: Describe updates to the COVID-19 pandemic's effect on the liver and its impact on hepatology and liver transplant providers.Help attendees to understand and review management strategies in patients with COVID-19 and chronic liver disease.Provide information regarding diagnostic antibody tests for SARS-CoV-2 exposure and…

22Apr 2020 by admin

Dr. Thomas presents SARS-CoV-2 Webinar on Youtube.

Dr. Emmanuel Thomas, American Liver Foundation National Board Member and professor at University of Miami's Miller School of Medicine, presented a webinar for Part Two of the American Liver Foundation web series Update on COVID-19 on April 6th, 2020. The webinar series provides a broader understanding of COVID-19 and SARS-CoV-2, testing, and why the virus is so unique. This recorded presentation is for patients, caregivers, medical professionals, or those just interested in taking a deeper dive on the issue. This program was made possible through an educational grant from Gilead. https://www.youtube.com/watch?v=6NRcF0MIVy8

21Apr 2020 by admin

The University of Miami Miller School of Medicine was awarded the Gilead Sciences “FOCUS Grant” to support identifying HIV and Hepatitis C infected patients, HIV and Hepatitis C testing, and testing-related services.

The University of Miami Miller School of Medicine has been awarded a $299,220 grant from Gilead Sciences, Inc., to develop a replicable model program that embodies best practices in HIV and/or hepatitis screening and linkage to care. The award is provided through Gilead’s Frontlines of Communities in the United States (FOCUS) Program. The grant application described that a growing body of research has shown that opt-out testing can play a strong role in getting more individuals tested, extending earlier and better care to people who have been infected, improving their quality of life and promoting better disease management. The FOCUS program will support local initiatives to identify and link to care patients infected with HIV and hepatitis C (HCV) at the University of Miami Miller School of Medicine Emergency Room while developing and…

20Apr 2020 by admin

Dr. Thomas has received a $2 million dollar grant from the FL Department of Health to study virus infection and progression of liver disease to liver cancer.

The Florida Department of Health has awarded Dr. Thomas the Bankhead-Coley Florida Clinical Cancer Research Grant to lead a research project titled "Identifying Infection and Molecular Determinants of Health Disparities in HCV Infected Minority Populations for the Prevention of HCC". The project is designed to address health disparities in minority populations with HCV-attributable liver disease in order to increase the early detection of HCC. The study aims to aid in the detection of high-risk subgroups and improve understanding of the progression of HCV disease after infection.